Dysplastic Nevi
Links shared publicly online about this topic
Moles, Dysplastic Nevi, and Melanoma
disabled-world.com — “Moles are usually tan brown or pink in color and may be either raised or flat approximately one in every ten people has at least one unusual form of mole” View full resource at disabled-world.com
Most Recently Shared on October 14, 2010 at 8:59 pm By:
Moles: Dr. Mejia Explains Dysplastic Nevi
dermatologyandhair.com — “A dysplastic nevi is an irregular mole. We all have many different types of moles in our body that need to be sent to biopsy.” View full resource at dermatologyandhair.com
Most Recently Shared on April 12, 2011 at 5:48 pm By:
Dr. Mejia explains Moles: "Dysplastic Nevi Is Not A Cancerous Mole" (video) #skincancer #prevention #melanoma http://ow.ly/4yG2Q
Dysplastic Nevi and the Risk of Melanoma: Current Evaluation and Management
nursingcenter.com — “-Dysplastic or atypical nevi are premalignant proliferations of melanocytes and are both a risk factor and a precursor for the development of melanoma. The ultimate goal of managing patients with dyspl” View full resource at nursingcenter.com
Most Recently Shared on September 25, 2009 at 2:00 am By:
NEW CE ~ Dysplastic Nevi and the Risk of Melanoma: Current Evaluation and Management http://bit.ly/2rGns8
The Skin Cancer Foundation - Dysplastic Nevi (Atypical Moles) | dysplastic
skincancer.org — “Dysplastic nevi, also known as atypical moles, are unusual benign moles that may resemble melanoma. People who have them are at an increased risk of melanoma. The larger the number of atypical moles, the greater the risk. Individuals with 10 or more of them have 12 times the risk of developing melanoma as members of the general public.” View full resource at skincancer.org
Most Recently Shared on August 4, 2010 at 5:28 pm By:
The Skin Cancer Foundation - Dysplastic Nevi (Atypical Moles) | dysplastic
skincancer.org — “Dysplastic nevi, also known as atypical moles, are unusual benign moles that may resemble melanoma. People who have them are at an increased risk of melanoma. The larger the number of atypical moles, the greater the risk. Individuals with 10 or more of them have 12 times the risk of developing melanoma as members of the general public.” View full resource at skincancer.org
Most Recently Shared on October 1, 2009 at 4:25 pm By:
Be sure to know about your risk of skin cancer. To find out more about Dysplastic Nevi or Atypical Moles http://bit.ly/7izll
Melanocytic Nevi - Dysplastic Nevi - Skin Conditions Explained - Anthony J. Perri, M.D.
perridermatology.com — “Melanocytic Nevi - Dysplastic Nevi - Skin Conditions Explained - Anthony J. Perri, M.D.” View full resource at perridermatology.com
Most Recently Shared on September 8, 2011 at 2:20 pm By:
Dysplastic Nevi are melanocytic nevi that usually have an atypical clinical appearance with multicoloration, irregular... http://ht.ly/6m1en
Clinics - Atypical mole syndrome and dysplastic nevi: identification of populations at risk for developing melanoma - review article
scielo.br — “Clinics - Atypical mole syndrome and dysplastic nevi: identification of populations at risk for developing melanoma - review article” View full resource at scielo.br
Most Recently Shared on May 7, 2011 at 7:58 pm By:
Atypical mole syndrome and dysplastic nevi: identification of populations at risk for developing melanoma - revi... http://bit.ly/kIkKM6
Atypical Mole (Dysplastic Nevus): eMedicine Dermatology
emedicine.medscape.com — “Overview: In 1820, Norris proposed an association between nevi and melanoma. He described a family in which 2 members developed melanoma, while other family members had many moles on various parts of their bodies. However, the exact ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 17, 2010 at 11:54 pm By:
Atypical moles may be inherited and may give rise to melanoma. Learn more about causes, symptoms & treatment. http://bit.ly/bejcvf
Immunohistochemical Reactivity of the 14F7 Monoclonal Antibody Raised against N-Glycolyl GM3 Ganglioside in Some Benign and Malignant Skin Neoplasms
hindawi.com — “The evaluation of 14F7 Mab (anti-N-glycolyl GM3 ganglioside) immunorecognition in normal skin, cutaneous malignant melanoma (CMM), and in lymph node metastases (LNM) has been previously reported. In this work we extended the study to benign (BMN) and dysplastic (DMN) melanocytic nevi, basal (BCC), and squamous cell carcinoma (SCC). Immunohistochemical assays with 14F7 followed by a biotinylated link universal and streptavidin-AP in normal and pathological tissues were made. No reaction of 14F7 i” View full resource at hindawi.com
Most Recently Shared on April 12, 2011 at 5:06 am By:
Immunohistochemical Reactivity of the 14F7 Monoclonal Antibody Raised against N-Glycolyl GM3 Ganglioside in Some... http://bit.ly/hLMvyZ
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Disabled World
Official Site - Disability News, Community, Videos. Article submissions welcome. Disability and Health RSS feeds for website content.
-
Ricardo Mejia M.D.
Dermatologist/Hair Transplant Surgeon/Mohs Skin Cancer Surgeon.Skin rejuvenation. I tweet after surgeries.Links/Info by my community mgr @miamishines ^bm
-
Lisa Morris Bonsall
MSN, RN, CRNP ~ Clinical editor for Lippincott's NursingCenter.com, the premier destination site for your clinical and professional informational needs
Advertisement

